Friday, July 10, 2026

pharma · Melanoma · Ovarian Cancer

Sandoz (Japan)

Sandoz Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Melanoma, Ovarian Cancer, Asthma. NovaPharmaNews links 4 clinical program(s), 8 drug profile(s), and 0 patent record(s) to

Basel, CH HQ
17,495 Employees
TGA registrant Type
Company details
Status
Public
HQ
Basel, CH
Employees
17,495
Programs
4
Drugs
22
Patents
0
Clinical program

SAN-1138

Phase 3 · small molecule · Asthma

SAN-1138 for Asthma is a Phase 3 program (small_molecule) at Sandoz Pty Ltd with 1 ClinicalTrials.gov record(s).

← All Sandoz Pty Ltd projects Phase 3 small molecule active

Internal code SAN-1138

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Sandoz Pty Ltd
Phase
Phase 3
Modality
small_molecule
Indication
Asthma
Status
active
Trials
1